Ricardo Fernández‐de‐Misa

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma

Yeray Peñate, B. Hernández‐Machín, Lina Pérez‐Méndez et al. · British Journal of Dermatology · 2012 · 73 citations

Medicine, Hematology, Pharmacotherapy +13

First-line treatment in lymphomatoid papulosis: a retrospective multicentre study

Ricardo Fernández‐de‐Misa, B. Hernández‐Machín, Octavio Servitje et al. · Clinical and Experimental Dermatology · 2017 · 40 citations · Full text

Medicine, Dermatology, Oncology +14

Melanoma Characteristics at Diagnosis From The Spanish National Cutaneous Melanoma Registry: 15 Years of Experience

L. Ríos, Eduardo Nagore, J. L. Lopez et al. · Actas Dermo-Sifiliográficas · 2013 · 38 citations · Full text

Medicine, Dermatology, Oncology +17

Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

Cristina Muniesa Montserrat, Fernando Gallardo, I. García‐Doval et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 25 citations

Medicine, Hematology, Oncology +11

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

V. Monsálvez, Santiago Montes‐Moreno, María J. Artiga et al. · Modern Pathology · 2012 · 24 citations · Full text

Medicine, Dermatology, Oncology +14